The transcriptomic profile of CD138 cells from patients with early progression from smoldering to active multiple myeloma remains substantially unchanged.
作者信息
Storti Paola, Agnelli Luca, Palma Benedetta Dalla, Todoerti Katia, Marchica Valentina, Accardi Fabrizio, Sammarelli Gabriella, Deluca Federica, Toscani Denise, Costa Federica, Vicario Emanuela, Todaro Giannalisa, Martella Eugenia, Neri Antonino, Giuliani Nicola
机构信息
Department of Medicine and Surgery, University of Parma, Parma
CORELAB Azienda Ospedaliero-Universitaria di Parma, Parma.
出版信息
Haematologica. 2019 Oct;104(10):e465-e469. doi: 10.3324/haematol.2018.209999. Epub 2019 Mar 7.
Abstract
摘要
相似文献
1
The transcriptomic profile of CD138 cells from patients with early progression from smoldering to active multiple myeloma remains substantially unchanged.从冒烟型多发性骨髓瘤早期进展为活动性多发性骨髓瘤患者的CD138细胞转录组图谱基本保持不变。
Haematologica. 2019 Oct;104(10):e465-e469. doi: 10.3324/haematol.2018.209999. Epub 2019 Mar 7.
2
Vascular endothelial growth factor receptor 3 is a novel marker differing CD138-positive and CD138-negative multiple myeloma cells.血管内皮生长因子受体3是区分CD138阳性和CD138阴性多发性骨髓瘤细胞的一种新型标志物。
Br J Haematol. 2018 Jun;181(6):840-843. doi: 10.1111/bjh.14706. Epub 2017 May 16.
3
Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease.在多发性骨髓瘤的骨髓微环境中，肝细胞生长因子通路的上调与溶骨性骨病有关。
Br J Haematol. 2013 May;161(3):373-82. doi: 10.1111/bjh.12270. Epub 2013 Feb 22.
4
Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.多发性骨髓瘤患者基线18F-FDG PET/CT检查结果与骨髓中表达CD38和CD138的骨髓瘤细胞及临床参数之间的相关性
Turk J Haematol. 2018 Aug 3;35(3):175-180. doi: 10.4274/tjh.2017.0372. Epub 2018 May 28.
5
Double CD38/CD138 negative multiple myeloma.双CD38/CD138阴性多发性骨髓瘤
Hematol Oncol Stem Cell Ther. 2019 Mar;12(1):64-66. doi: 10.1016/j.hemonc.2017.08.003. Epub 2017 Oct 18.
6
CD138 shedding in plasma cell myeloma.浆细胞骨髓瘤中的CD138脱落
Br J Haematol. 2010 Aug;150(3):249. doi: 10.1111/j.1365-2141.2010.08203.x. Epub 2010 Apr 23.
7
Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry.多发性骨髓瘤中骨髓浆细胞浸润的评估：CD138免疫组织化学的附加价值
Hum Pathol. 2007 Dec;38(12):1779-87. doi: 10.1016/j.humpath.2007.04.010. Epub 2007 Aug 21.
8
Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivo.Syndecan-1是骨髓瘤肿瘤在体内实现强劲生长、血管生成和转移所必需的。
J Biol Chem. 2009 Sep 18;284(38):26085-95. doi: 10.1074/jbc.M109.018473. Epub 2009 Jul 13.
9
Increased Muscle CXCR4 Expression in the Setting of Rare Muscle-invasive Multiple Myeloma.
Clin Lymphoma Myeloma Leuk. 2020 Jun;20(6):e341-e344. doi: 10.1016/j.clml.2020.02.016. Epub 2020 Mar 7.
10
Granulocyte colony stimulating factor-producing multiple myeloma associated with neutrophilia.粒细胞集落刺激因子产生型多发性骨髓瘤伴中性粒细胞增多症
Leuk Lymphoma. 2004 Jul;45(7):1475-9. doi: 10.1080/10428190310001645870.
引用本文的文献
1
Single-Cell RNA Sequencing before and after Light Chain Escape Reveals Intrapatient Multiple Myeloma Subpopulations with Divergent Osteolytic Gene Expression.轻链逃逸前后的单细胞RNA测序揭示了患者体内具有不同溶骨性基因表达的多发性骨髓瘤亚群。
Cancer Res Commun. 2025 Jan 1;5(1):106-118. doi: 10.1158/2767-9764.CRC-24-0170.
2
BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma.BCMA/CD47 双靶向通用 CAR-T 细胞在多发性骨髓瘤中表现出优异的抗肿瘤活性。
J Nanobiotechnology. 2024 May 23;22(1):279. doi: 10.1186/s12951-024-02512-6.
3
Identification of and as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma.鉴定 和 作为与冒烟型骨髓瘤和多发性骨髓瘤患者1q21扩增相关的新靶基因。
Haematologica. 2024 Feb 1;109(2):627-631. doi: 10.3324/haematol.2023.283200.
4
Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma.在单细胞分辨率下解析多发性骨髓瘤中的空间基因组异质性。
Nat Commun. 2022 Feb 10;13(1):807. doi: 10.1038/s41467-022-28266-z.
5
Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression.骨髓瘤小鼠模型的纵向单细胞分析确定了与进展相关的亚克隆分子程序。
Nat Commun. 2021 Nov 3;12(1):6322. doi: 10.1038/s41467-021-26598-w.
6
ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape.ZNF521 通过改变基因表达图谱增强 MLL-AF9 依赖性急性髓系白血病中的造血干细胞转化。
Int J Mol Sci. 2021 Oct 6;22(19):10814. doi: 10.3390/ijms221910814.
7
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability.骨髓瘤细胞消耗骨髓谷氨酰胺并抑制成骨细胞分化，限制天冬酰胺的可用性。
Cancers (Basel). 2020 Nov 5;12(11):3267. doi: 10.3390/cancers12113267.
8
How we manage smoldering multiple myeloma.我们如何管理冒烟型多发性骨髓瘤。
Hematol Rep. 2020 Sep 21;12(Suppl 1):8951. doi: 10.4081/hr.2020.8951.
9
Recent updates on CAR T clinical trials for multiple myeloma.多发性骨髓瘤嵌合抗原受体 T 细胞临床试验的最新进展。
Mol Cancer. 2019 Nov 5;18(1):154. doi: 10.1186/s12943-019-1092-1.
本文引用的文献
1
The long non-coding RNA landscape in juvenile myelomonocytic leukemia.青少年骨髓单核细胞白血病中的长链非编码RNA图谱
Haematologica. 2018 Nov;103(11):e501-e504. doi: 10.3324/haematol.2018.189977. Epub 2018 Jun 1.
2
From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells.从意义未明的单克隆丙种球蛋白血症到多发性骨髓瘤：恶性前体细胞克隆进化的范例。
Cancer Res. 2018 May 15;78(10):2449-2456. doi: 10.1158/0008-5472.CAN-17-3115. Epub 2018 Apr 27.
3
Long non coding RNA XIST as a prognostic cancer marker - A meta-analysis.长非编码 RNA XIST 作为一种预后肿瘤标志物的Meta 分析。
Clin Chim Acta. 2018 Jul;482:1-7. doi: 10.1016/j.cca.2018.03.016. Epub 2018 Mar 23.
4
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma.骨髓中Dickkopf-1水平是冒烟型骨髓瘤患者病情进展的一个新的独立危险因素。
Br J Haematol. 2018 Dec;183(5):812-815. doi: 10.1111/bjh.15026. Epub 2017 Nov 16.
5
Evolutionary biology of high-risk multiple myeloma.高危多发性骨髓瘤的进化生物学。
Nat Rev Cancer. 2017 Aug 24;17(9):543-556. doi: 10.1038/nrc.2017.63.
6
Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemia.长链非编码RNA特征定义了T细胞急性淋巴细胞白血病的致癌亚型。
Leukemia. 2016 Sep;30(9):1927-30. doi: 10.1038/leu.2016.82. Epub 2016 Apr 22.
7
Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer.Dickkopf相关蛋白1（Dkk1）调节癌症中髓源性抑制细胞的积累和功能。
J Exp Med. 2016 May 2;213(5):827-40. doi: 10.1084/jem.20150950. Epub 2016 Apr 4.
8
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma.独特的长链非编码RNA转录指纹图谱可表征多发性骨髓瘤的进展阶段。
Oncotarget. 2016 Mar 22;7(12):14814-30. doi: 10.18632/oncotarget.7442.
9
Pathway-based network analysis of myeloma tumors: monoclonal gammopathy of unknown significance, smoldering multiple myeloma, and multiple myeloma.骨髓瘤肿瘤的基于通路的网络分析：意义未明的单克隆丙种球蛋白病、冒烟型多发性骨髓瘤和多发性骨髓瘤。
Genet Mol Res. 2015 Aug 14;14(3):9571-84. doi: 10.4238/2015.August.14.20.
10
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120).四个基因可预测无症状多发性骨髓瘤进展为有症状多发性骨髓瘤的高风险（SWOG S0120）。
Haematologica. 2015 Sep;100(9):1214-21. doi: 10.3324/haematol.2015.124651. Epub 2015 May 28.
Zotero 插件